Clinical

Dataset Information

Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases


ABSTRACT: RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Giving drugs in different ways may kill more tumor cells. PURPOSE: This phase II trial is studying how well isolated hepatic perfusion with melphalan works in treating patients with primary unresectable liver cancer or liver metastases.

DISEASE(S): Carcinoma,Adenoma, Islet Cell,Carcinoma, Neuroendocrine,Colorectal Cancer,Islet Cell Tumor,Liver Cancer,Neuroendocrine Carcinoma,Liver Neoplasms,Metastatic Cancer

PROVIDER: 2006419 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR